James Sferra, M.D.

James Sferra, MD, has been on Staff in the Department of Orthopaedic Surgery at Cleveland Clinic since 1993. He has been Head of the Section of Foot and Ankle Surgery since 1996. Dr. Sferra’s practice is limited to pathology of the foot and ankle region. His interests include sports medicine, fractures, bunion and lesser toe deformities and occupational injuries.

Dr. Sferra is an active member of the American Orthopaedic Foot and Ankle Society along with the American Academy of Orthopaedic Surgeons. He has served on AOFAS committees and has given graduate medical education courses on behalf of the AOFAS and AAOS.

Dr. Sferra has numerous publications in orthopaedic peer-reviewed journals and has contributed to a multitude of textbooks. He serves as a reviewer for Clinical Orthopaedics and Related Research, and editor for Techniques in Foot and Ankle Surgery, Journal for Prosthetics and Orthotics and the American Journal of Orthopaedics.

Distinguished Orthopaedic Resident's Teaching Award, 2002-2003

All aspects of foot and ankle reconstruction.

• American Academy of Orthopaedic Surgeons
• American Orthopaedic Foot and Ankle Society
• North American Foot and Ankle Association
• Mid-America Orthopaedic Association
• Cleveland Orthopaedic Society

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 10/10/2008, Dr. Sferra has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting.  Dr. Sferra receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:

• Acumed

Equity.  Dr. Sferra owns stock or stock options in the following companies for activities as a founder, inventor, or consultant:

• Orthohelix

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)